The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Use of Collateral Sensitivity Networks to Design Drug Cycling Protocols That Avoid Resistance Development
Open accessAbstract
Elucidation of complex collateral sensitivity networks provides rationale for new sequential drug deployment strategies that restrain antibiotic resistance development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002
Klevens, R. M., Edwards, J. R., Richards, C. L., Horan, T. C., Gaynes, R. P., Pollock, D. A., & Cardo, D. M. (2007) · Public Health Reports® · doi:10.1177/003335490712200205 · Cited by 2,960
Global Burden of Disease and Risk Factors
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,605
Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., & Pittet, D. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61458-4 · Cited by 2,514
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,885
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Lutz, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.6.1203 · Cited by 1,693
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Lee, M. J., Ye, A. S., Gardino, A. K., Heijink, A. M., Sorger, P. K., MacBeath, G., & Yaffe, M. B. (2012) · Cell · doi:10.1016/j.cell.2012.03.031 · Cited by 680
The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis
Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik, G. K., & Bohannan, B. J. M. (2006) · Science · doi:10.1126/science.1124410 · Cited by 627
Effects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic Resistance
Björkman, J., Nagaev, I., Berg, O. G., Hughes, D., & Andersson, D. I. (2000) · Science · doi:10.1126/science.287.5457.1479 · Cited by 452
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Szybalski, W., & Bryson, V. (1952) · Journal of Bacteriology · doi:10.1128/jb.64.4.489-499.1952 · Cited by 421
Mutant Selection Window Hypothesis Updated
Drlica, K., & Zhao, X. (2007) · Clinical Infectious Diseases · doi:10.1086/511642 · Cited by 383
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Raviglione, M., Marais, B., Floyd, K., Lönnroth, K., Getahun, H., Migliori, G. B., Harries, A. D., Nunn, P., Lienhardt, C., Graham, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60727-2 · Cited by 340
Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
Marcusson, L. L., Frimodt-Møller, N., & Hughes, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000541 · Cited by 320
Collateral sensitivity as a strategy against cancer multidrug resistance
Pluchino, K. M., Hall, M. D., Goldsborough, A. S., Callaghan, R., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.03.002 · Cited by 305
Liu, A., Tran, L., Becket, E., Lee, K., Chinn, L., Park, E., Tran, K., & Miller, J. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-09 · Cited by 286
Combination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Tamae, C., Liu, A., Kim, K., Sitz, D., Hong, J., Becket, E., Bui, A., Solaimani, P., Tran, K. P., Yang, H., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.01982-07 · Cited by 234
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Romano, K. P., Ali, A., Aydin, C., Soumana, D., Özen, A., Deveau, L. M., Silver, C., Cao, H., Newton, A., Petropoulos, C. J., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002832 · Cited by 219
Borst, P. (2012) · Open Biology · doi:10.1098/rsob.120066 · Cited by 212
Antibiotic cycling or rotation: a systematic review of the evidence of efficacy
Brown, E. M., & Nathwani, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh482 · Cited by 201
Sundqvist, M., Geli, P., Andersson, D. I., Sjolund-Karlsson, M., Runehagen, A., Cars, H., Abelson-Storby, K., Cars, O., & Kahlmeter, G. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp387 · Cited by 179
Kucers' The Use of Antibiotics
(2017) · CRC Press eBooks · doi:10.1201/9781498747967 · Cited by 169
Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV
Goldberg, D. E., Siliciano, R. F., & Jacobs, W. R. (2012) · Cell · doi:10.1016/j.cell.2012.02.021 · Cited by 168
Selection of resistance at lethal and non-lethal antibiotic concentrations
Hughes, D., & Andersson, D. I. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.07.005 · Cited by 163
Genetic Studies on Microbial Cross Resistance to Toxic Agents
Szybalski, W. (1954) · Applied Microbiology · doi:10.1128/am.2.2.57-63.1954 · Cited by 135
Appropriate use of antimicrobial agents: Challenges and strategies for improvement
Niederman, M. S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050464.70382.d6 · Cited by 124
Antimicrobial Stewardship Programs in Community Hospitals: The Evidence Base and Case Studies
Ohl, C. A., & Ashley, E. S. D. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir365 · Cited by 116
Antibiotic Rotation and Development of Gram-Negative Antibiotic Resistance
van Loon, H.-J., Vriens, M. R., Fluit, A. C., Troelstra, A., van der Werken, C., Verhoef, J., & Bonten, M. J. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-070oc · Cited by 96
Kucers' The Use of Antibiotics
Grayson, M. L., Crowe, S. M., McCarthy, J. S., Mills, J. L., Mouton, J. W., Norrby, S. R., Paterson, D. L., & Pfaller, M. A. (2010) · CRC Press eBooks · doi:10.1201/b13787 · Cited by 86
Impaired Fitness and Transmission of Macrolide-Resistant Campylobacter jejuni in Its Natural Host
Luangtongkum, T., Shen, Z., Seng, V. W., Şahin, O., Jeon, B., Liu, P., & Zhang, Q. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05516-11 · Cited by 62
Antibiotic cycling: more than it might seem?
Masterton, R. G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh506 · Cited by 59
Antibiotic heterogeneity: from concept to practice
Bal, A. M., Kumar, A., & Gould, I. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05867.x · Cited by 51
Rodríguez-Rojas, A., Macia, M. D., Couce, A., Gómez, C., Castañeda-García, A., Oliver, A., & Blázquez, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010193 · Cited by 45
Cited by
Antimicrobial peptides: Application informed by evolution
Lazzaro, B. P., Zasloff, M., & Rolff, J. (2020) · Science · doi:10.1126/science.aau5480 · Cited by 1,069
Antibacterial Coatings: Challenges, Perspectives, and Opportunities
Cloutier, M., Mantovani, D., & Rosei, F. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.09.002 · Cited by 813
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
Multidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Antimicrobial resistance in humans, livestock and the wider environment
Woolhouse, M., Ward, M., van Bunnik, B., & Farrar, J. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0083 · Cited by 678
Metadata
- Authors
- Imamovic, L., & Sommer, M. O. A.
- Venue
- Science Translational Medicine
- Published
- 2013-09-25
- Volume
- 5
- Issue
- 204
- Pages
- 204ra132-204ra132
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W1983042430
- Cited by
- 444
- References
- 42
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.